2012-10-10T12:27:21-05:00 2010-06-30 PricewaterhouseCoopers LLP 2001 MARKET ST SUITE 1700 PHILADELPHIA PA 19103 990 2009-07-01 232003072 FOX CHASE CANCER CENTER FOXC 2157282457 333 COTTMAN AVENUE PHILADELPHIA PA 19111 THOMAS S ALBANESI JR 2012-10-09 2673303000 2009 2016-02-24 21:20:13Z X MICHAEL V SEIDEN MD PHD 333 COTTMAN AVENUE PHILADELPHIA PA 19111 59091497 false X WWW.FCCC.EDU X 1963 DE TO PREVAIL OVER CANCER, MARSHALING HEART AND MIND IN BOLD SCIENTIFIC DISCOVERY, PIONEERING PREVENTION AND COMPASSIONATE CARE. 25 23 842 58 0 39039928 39505090 13901106 1973840 2233001 1860472 684122 1962923 55858157 45302325 0 0 0 0 55839424 49394151 489619 0 2451233 8169475 7046376 64498518 56440527 -8640361 -11138202 181643167 187039013 133529980 134497861 48113187 52541152 TO PREVAIL OVER CANCER, MARSHALING HEART AND MIND IN BOLD SCIENTIFIC DISCOVERY, PIONEERING PREVENTION AND COMPASSIONATE CARE. false false 26343205 1973840 RESEARCHERS AT FOX CHASE INVESTIGATE PROBLEMS THAT RANGE FROM UNDERSTANDING THE FUNDAMENTAL MECHANISMS OF BIOMOLECULOR REACTIONS ALL THE WAY TO THE TREATMENT OF NEOPLASTIC DISEASES IN THE CLINIC. THE SCIENCE IS CONDUCTED WITH FOX CHASES'S COMMITMENT TO RESEARCH AND INTERDISCIPLINARY INTERACTION. CURRENT FACULTY RESEARCH PROGRAMS ARE WIDE-RANGING AND INCLUDE CANCER BIOLOGY IDENTIFYING SUITABLE TARGETS FOR INTERVENTION IN CANCER AND USING THIS INFORMATION TO INFORM NOVEL PRECLINICAL STUDIES AND CLINICAL TRIALS THAT TARGET COOPERATING CANCER-PROMOTING PATHWAYS. CANCER PREVENTION AND CONTROL INTEGRATING BASIC AND APPLIED RESEARCH IN THE AREAS OF CHEMOPREVENTION, MEDICAL SCIENCE, AND THE BEHAVIORAL, SOCIAL AND POPULATION SCIENCES IMMUNE CELL DEVELOPMENT AND HOST DEFENSE FOCUSING ON THE BIOLOGY OF IMMUNE CELLS-FROM HOW THEY DEVELOP TO HOW THEY FUNCTION, PRINCIPALLY IN THE CONTENT OF VIRAL INFECTIONS. DEVELOPMENTAL THERAPEUTICS SEEING TO UNDERSTAND THE FUNDAMENTAL MOLECULAR EVENTS THAT DRIVE CANCER AND UTILIZE THIS KNOWLEDGE TO CREATE NEW THERAPEUTIC AGENTS AND IMPROVE THE APPLICATION OF EXISTING AGENTS. WOMENS CANCER FOCUSING ON THE DEVELOPMENT OF TRANSLATIONAL STUDIES OF PREVENTION, RISK REDUCTION, BEHAVIORAL STUDIES OF PREVENTION, RISK REDUCTION, BEHAVIORAL MEDICINE AND TREATMENT THROUGH INTERACTIONS OF BASIC SCIENCE AND INVESTIGATORS. 14272227 THE RESEARCH FACILITIES HAVE BEEN STRUCTURED TO FULFILL THE NEEDS OF THE MULTI-DISCIPLINARY RESEARCH PROGRAMS AT FOX CHASE CANCER CENTER. THE FACILITIES HAVE BEEN DESIGNED TO ENHANCE ON-GOING RESEARCH BY SUPPLYING INFORMATION, REAGENTS, AND TECHNICAL EXPERTISE THAT ARE NOT READILY AVAILABLE TO THE INDIVIDUAL INVESTIGATOR. 40615432 true true false true false false false false true true false true false false false false false false true false false false false true true false false false false false false false false false true false false false true true false false true 0 0 true 842 true false false false false false false false false false 25 23 false false false false false false false true true false true true false true true true true true true true false NJ NY PA X THOMAS S ALBANESI JR CFO 2157282457 604 COTTMAN AVENUE CHELTENHAM PA 19012 MICHAEL V SEIDEN MD PHD 5.0 X X 537890 0 15973 WILLIAM J AVERY 1.0 X 0 0 0 W THACHER BROWN 1.0 X 0 0 0 LOUIS E DELLA PENNA SR 1.0 X 0 0 0 G MORRIS DORRANCE JR 1.0 X 0 0 0 EDWARD A GLICKMAN 1.0 X 0 0 0 THE HONORABLE DWIGHT EVANS 1.0 X 0 0 0 THOMAS W HOFMANN 1.0 X 0 0 0 LAWRENCE T HOYLE JR ESQ 1.0 X 0 0 0 MICHAEL J HELLER ESQ 1.0 X 0 0 0 PETER MCCAUSLAND 1.0 X 0 0 0 JILL MICHAL 1.0 X 0 0 0 MARGOT W KEITH 1.0 X 0 0 0 THOMAS SHENK PHD 1.0 X 0 0 0 PHILIP E LIPPINCOTT 1.0 X 0 0 0 WILLIAM G LITTLE 1.0 X 0 0 0 PAMELA STRISOFSKY 1.0 X 0 0 0 DAVID G MARSHALL 1.0 X 0 0 0 WILLIAM STULGINSKY 1.0 X 0 0 0 DONALD E MOREL JR PHD 1.0 X 0 0 0 JANE G PEPPER 1.0 X 0 0 0 THOMAS R TRITTON PHD 1.0 X 0 0 0 KENNETH E WEG 1.0 X 0 0 0 YORAM JERRY WIND PHD 1.0 X 0 0 0 DEBRA SNIGER EX OFFICIO 1.0 X 0 0 0 J ROBERT BECK MD 5.0 X 364444 0 8849 JEFFERY BOYD PHD 5.0 X 425413 0 21796 PAUL F ENGSTROM MD 5.0 X 431552 0 17465 JOSEPH HEDIGER 5.0 X 318627 0 17095 JILL L MARSTELLER 5.0 X 234548 0 13842 SUSAN H TOFANI 5.0 X 311496 0 5127 GARY J WEYHMULLER 5.0 X 311538 0 21545 ROBERT G WILKENS 5.0 X 69406 0 0 MARY B DALY MD PHD 40.0 X 345309 0 10391 ANNA M SKALKA PHD 40.0 X 305785 0 17474 ANTHONY J DIASIO 40.0 X 213892 0 17858 ROBERT C YOUNG 40.0 X 206344 0 12472 JOANNE M HAMBLETON 40.0 X 207692 0 3669 KURT SCHWINGHAMMER 40.0 X 181173 0 2647 ROBERT SPALLONE 40.0 X 186895 0 14377 DOROTHY A RIEHS 40.0 X 248456 0 20150 THOMAS K GARVEY 40.0 X 149948 0 2887 JOSEPH A PICCOLO 40.0 X 106100 0 0 GEORGE R SIMON 40.0 X 322993 0 18553 SHARON L MANNE 40.0 X 208756 0 9216 JOSE RUSSO MD FACP 40.0 X 246640 0 3591 SUSAN M MILLER PHD 40.0 X 240645 0 9925 JOSEPH R TESTA PHD 40.0 X 238195 0 8945 R DONALD LEEDY 5.0 X 176102 0 0 CHRISTINE WILSON 40.0 X 146872 0 0 6736711 0 273847 110 true true false P AGNES INC 2101 PENROSE AVENUE PHILADELPHIA PA 19145 PROFESSIONAL SERVICE 8445475 FTI HEALTHCARE PO BOX 630391 BALTIMORE MD 21263 PROFESSIONAL SERVICE 2229993 HARMELIN MEDIA 525 RIGHTERS FERRY ROAD BALA CYNWYD PA 19004 PROFESSIONAL SERVICE 1908853 MOUNT SINAI SCHOOL OF MEDICINE 1 GUSTAVE L LEVY PLACE NEW YORK NY 10029 PROFESSIONAL SERVICE 746705 GEORGETOWN UNIVERSITY 37TH O STREETS BOX 571164 WASHINGTON DC 20057 PROFESSIONAL SERVICE 620003 17 7748 31139851 8357491 39505090 RESEARCH REVENUE 1973840 1973840 1973840 130909 130909 -1843893 -1843893 0 17032352 13458896 3573456 3573456 3573456 447413 7748 216660 230753 230753 0 1421286 113616 1307670 1307670 MISC REVENUE 900099 424500 424500 424500 45302325 1973840 3823395 0 0 0 0 6842056 2041939 4800117 0 30902609 19564700 9671753 1666156 433478 248141 166202 19135 8631679 5340267 2920885 370527 2584329 1479379 990870 114080 0 835795 9151 826644 60513 60513 0 0 0 5033421 3045580 1103471 884370 170102 88709 56552 24841 303528 105535 169049 28944 177069 177069 0 1811166 1529217 281949 600924 354822 230056 16046 0 291175 152941 117151 21083 2785197 863411 1921786 -22885768 1144288 -23572341 -457715 5706134 1783202 3922932 0 PURCHASE SERVICES 11980051 2808815 9407470 -236234 LEASES 177069 55335 121734 56440527 40615432 13373862 2451233 4480603 2215926 393147 231315 18607151 9091095 2690479 3178343 351153 1794623 134091518 35870274 93840515 98221244 29961262 32449983 725197 420113 3804539 419005 26789121 39017366 181643167 187039013 16786769 13286417 8708189 8341955 72023649 70821072 0 0 14000000 14950000 0 0 22011373 27098417 133529980 134497861 X 1130916 16713252 18544719 7369995 28437552 28457905 48113187 52541152 181643167 187039013 X false true true X true true X 57729263 52575222 50517563 50944471 45898962 257665481 0 0 0 0 0 0 0 0 0 0 57729263 52575222 50517563 50944471 45898962 257665481 257665481 787585 496676 1801099 -373244 -1835283 876833 258542314 5170846 0.99661 0.98744 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 10600 50284 10600 50284 53894495 335334783 53905095 335385067 1000000 1000000 250000 250000 false 1000000 1000000 1000000 1000000 4000000 6000000 54667 57747 157246 50284 319944 250000 250000 250000 250001 1000001 1500002 0 0 PART I-A LINE 1 MANAGEMENT HAS DIRECT CONTACT WITH LEGISLATORS, THEIR STAFFS, AND GOVERMENT OFFICIALS TO ADVOCATE THE CENTER'S POSITION ON KEY ISSUES AFFECTING THE CENTER. FREQUENTLY, THESE CONTACTS ARE MADE TO EDUCATE THE APPROPRIATE REPRESENTATIVE OR OFFICIAL ON THE IMPLICATIONS OF SPECIFIC POLICY/LEGISLATION ON THE INDUSTURY IN GENERAL AND/OR IMPLICATIONS TO FOX CHASE. AT THE FEDERAL LEVEL, DURING FY 2010, THE CENTER ADVOCATED FOR INCREASED MEDICARE REIMBURSEMENT UNDER THE CANCER CENTER RULES AND ADVOCATED FOR INCREASED RESEARCH FUNDING THE NIH AND NCI. MANAGEMENT ALSO PROVIDED INPUT ON VARIOUS ISSUES INCLUDING HEALTH CARE REFORM AND IMPORTANT ISSUES SUCH AS DRUG SHORTAGES LEGISLATION. ADDITIONALLY, TO ASSIST THE CENTER OBTAIN NEEDED FUNDING FOR CUTTING EDGE TECHNOLOGIES AND RESOURCES USED BY THE SCIENTIFIC AND CLINICAL FACULTY, THE CENTER SUBMITTED FEDERAL GRANTS THROUGH THE APPROPRIATION MECHANISMS. AT THE STATE LEVEL, MANAGEMENT ADVOCATED FOR THE SUSTAINED USE OF TOBACCO FUNDS TO SUPPORT THE VARIOUS CANCER PROGRAMS IN THE COMMONWEALTH. THIS FUNDING IS CENTRAL TO THE PROGRAMS CONDUCTED BY THE CENTER IN CANCER RESEARCH, PREVENTION, SCREENING AND TREATMENT. MANAGEMENT ALSO MET WITH VARIOUS STATE REPRESENTATIVES TO OBTAIN FUNDING FOR CAPITAL AND OPERATING PROGRAMS UNDER THE VARIOUS APPROPRIATION MECHANISMS TO SUPPORT ECONOMIC DEVELOPMENT OPPORTUNITIES. 29961262 637869 2831787 555935 425000 32449983 48393986 3952028 -9589495 1669947 11125310 0 29961262 0.03000 0.80000 0.17000 false true true 350000 350000 43219057 23844726 19374331 512682 185942 326740 23323592 11382972 11940620 61848824 61848824 93840515 OTHER ASSETS 2707086 DUE FROM AFFILIATES 36310280 39017366 0 POST-RETIREMENT BENEFITS 9291047 SERVICE PAY 583000 ESCHEAT PAYABLE 8822 ENVIRONMENTAL LIABILITIES 734047 INTEREST RATE SWAPS 15714838 ANNUITY LIABILITY 574835 ASSET RETIREMENT OBLIGATION 5297 MISC 7325 AFFILIATE BALANCE -17269598 9649613 PART V, LINE 4 Appointment to an endowed chair rewards a scientist's professional contributions, recognizes the value of his or her research endeavors and safeguards the funding needs to continue these pioneering inquiries. Those who support a chair endowment become vital partners in our scientists groundbreaking, lifesaving discoveries. Endowing and naming a chair provides the opportunity to honor a loved one with a memorial that will last for many years. Endowed chairs provide a steady and predictable flow of funds in perpetuity allowing the institutions to strengthen the quality of its programs and services beyond levels that other funding sources alone could support. Board designated funds give researchers the flexible funds to initiate new programs for the prevention, detection, and treatment of cancer. The funds assist patients and their families to receive the best support and provide important services to the community. L W ROBBINS ASSOCIATES MANAGEMENT SERVICES false MARTS LUNDY CONSULTANT FEES false GARDEN PARTY 124472 124472 29796 PLAIN FANCY 47656 47656 12639 2 283033 7748 275285 174225 455161 7748 447413 216660 216660 230753 X X X X X true false false false false false false false false MICHAEL V SEIDEN MD PHD 492692 0 0 0 45198 0 0 0 15973 0 553863 0 0 0 J ROBERT BECK MD 352848 0 11596 0 0 0 2615 0 6234 0 373293 0 0 0 JEFFERY BOYD PHD 363462 0 0 0 61951 0 2692 0 19104 0 447209 0 0 0 PAUL F ENGSTROM MD 429752 0 1800 0 0 0 2297 0 15168 0 449017 0 0 0 JOSEPH HEDIGER 311527 0 0 0 7100 0 2308 0 14787 0 335722 0 0 0 JILL L MARSTELLER 230358 0 0 0 4190 0 2308 0 11534 0 248390 0 0 0 SUSAN H TOFANI 311496 0 0 0 0 0 2308 0 2819 0 316623 0 0 0 GARY J WEYHMULLER 311538 0 0 0 0 0 2308 0 19237 0 333083 0 0 0 GEORGE R SIMON 321923 0 1000 0 70 0 2385 0 16168 0 341546 0 0 0 R DONALD LEEDY 173385 0 0 0 2717 0 0 0 0 0 176102 0 0 0 MARY B DALY MD PHD 329732 0 15577 0 0 0 2492 0 7899 0 355700 0 0 0 ANNA M SKALKA PHD 305785 0 0 0 0 0 3404 0 14070 0 323259 0 0 0 ANTHONY J DIASIO 213892 0 0 0 0 0 1585 0 16273 0 231750 0 0 0 ROBERT C YOUNG 181029 0 25000 0 315 0 2550 0 9922 0 218816 0 0 0 CHRISTINE WILSON 141795 0 0 0 5077 0 0 0 0 0 146872 0 0 0 SHARON L MANNE 194577 0 0 0 14179 0 1441 0 7775 0 217972 0 0 0 JOANNE M HAMBLETON 207692 0 0 0 0 0 1538 0 2131 0 211361 0 0 0 KURT SCHWINGHAMMER 181173 0 0 0 0 0 1314 0 1333 0 183820 0 0 0 JOSE RUSSO MD FACP 246640 0 0 0 0 0 1827 0 1764 0 250231 0 0 0 ROBERT SPALLONE 180324 0 0 0 6571 0 1720 0 12657 0 201272 0 0 0 SUSAN M MILLER PHD 237095 0 0 0 3550 0 8169 0 1756 0 250570 0 0 0 DOROTHY A RIEHS 227302 0 21154 0 0 0 1466 0 18684 0 268606 0 0 0 THOMAS K GARVEY 19808 0 27140 0 103000 0 1585 0 1302 0 152835 0 0 0 JOSEPH R TESTA PHD 225588 0 12607 0 0 0 1671 0 7274 0 247140 0 0 0 PHILADELPHIA AUTHORITY FOR INDUSTRIAL DEVELOPMENT 232237287 7178182F4 2007-09-28 56530000 REFUND & CONSTRUCT, MED FACIL, PAR false false PHILADELPHIA AUTHORITY FOR INDUSTRIAL DEVELOPMENT 232237287 7178182G2 2007-09-28 23645000 REFUND & CONSTRUCT, MED FACIL, PAR false false PHILADELPHIA AUTHORITY FOR INDUSTRIAL DEVELOPMENT 232237287 7178182H0 2007-09-28 16375000 REFUND & CONSTRUCT, MED FACIL, PAR false false PHILADELPHIA AUTHORITY FOR INDUSTRIAL DEVELOPMENT 232237287 7178182J6 2007-09-28 27800000 REFUND & CONSTRUCT, MED FACIL, PAR false false 56530000 2761832 599105 20470320 2010 true false true true 23645000 302769 19432231 2010 true false true true 16375000 191564 2135000 2010 true false true true 27800000 437214 31272786 2010 false false true true false true true true false 0.00384 0.00384 true false true true true false 0.00384 0.00384 true false true true true false 0.00384 0.00384 true false true true true false 0.00384 0.00384 true false true false true MORGAN STANLEY 2.17 true false true false false true JP MORGAN 7. true MORGAN STANLEY 2.17 true false true false false true JP MORGAN 7. true MORGAN STANLEY 2.17 true false true false false true jp morgan 7. true MORGAN STANLEY 2.17 true false true X 4 THIRD PARTY APPRAISA false true true FORM 990 PART III LINE 2 IN MAY 2009, FOX CHASE LAUNCHED THE INSTITUTE FOR PERSONALIZED MEDICINE, A PROGRAM AIMED AT MATCHING EMERGING TARGETED DRUG THERAPIES TO THE UNIQUE GENETIC PROFILES OF INDIVIDUAL PATIENT TUMORS. ITS FIRST AMBITIOUS PROJECTS FOCUSED ON UNDERSTANDING THE BIOLOGY OF RATE TYPES OF SARCOMA AND OVARIAN CANCER. THE INSTITUTE BUILDS ON FOX CHASES' ALREADY SUBSTANTIAL ANNOTATED BIOSAMPLE REPOSITORY AND TUMOR BANK TO ADD NEW LAYERS OF KNOWLEDGE ABOUT THE GENETIC INFORMATION IN INDIVIDUAL PATIENT TUMORS. FORM 990, PART VI, SECTION A, LINE 11A THE amended FORM 990 IS PREPARED BY PWC AND REVIEWED BY SEVERAL MEMBERS OF THE FINANCE DEPARTMENT INCLUDING BOTH THE VICE PRESIDENT - FINANCE AND THE SR. VICE PRESIDENT - FINANCE, CFO, MEMBERS OF THE SENIOR LEADERSHIP COMMITTEE AND THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS IS PROVIDED A COPY OF THE FORM 990 AT THEIR NEXT BOARD MEETING. FORM 990 PART VI SECTION B LINE 12 In the case of potential conflict of interest or commitment, the President of FCCC shall be responsible for administering all matters. All disclosures shall be kept confidential, in a separate file under the control of the Office of the President. They shall not be made part of any personnel record or the basis for any review of the performance of the individual staff member. Access to these record shall be made available only to Board members, the President or his designee or a properly authorized governmental body, acting under statutory or regulatory authority. Record will be maintained for three years unless the materials are subject to governmental action. Disclosures shall be required of all staff and board members as follows: By Board Members: All Board Members of FCCC shall be required to complete a Conflict of Interest Disclosure form at the time of appointment, annually and whenever a new potential conflict arises. By Employees: All scientists, physicians and administrative employees at the management level and above of FCCC shall be required to complete a Conflict of Interet form at the time of employment, annually and whenever a new potential conflict arises and submit such disclosure forms to the Chief Academic Officer or his designee. By Consultants and Subcontractors: Consultants and Subcontractors shall certify to FCCC that they are not in a position to influence Center business, research or other decisions in ways that could lead to any form of personal gain from them or their family or give improper advantage to others to the Center's detriment. FORM 990 PART VI SECTION B LINE 15 THE ORGANIZATION'S COMPENSATION POLICY FOR THE POSITIONS OF CEO, EXECUTIVE DIRECTORS, SENIOR MANAGEMENT, OFFICERS AND OR KEY EMPLOYEES IS TO UTILIZE A NATIONAL SURVEY FACILITY FOR COMPENSATION INFORMATION. IT IS REVIEWED BY THE ORGANIZATION'S COMPENSATION COMMITTEE AS WELL AS THE BOARD FOR APPROVAL. FORM 990 PART VI SECTION C LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC WHEN REQUESTED. FORM SCHEDULE K The Bonds were issued by the Fox Chase Cancer Center on behalf of itself and Institute for Cancer Research and American Oncologic Hospital via Master Trust Indentures. Under the terms of the indentures, the bonds are joint and several liabilities of Fox Chase Cancer Center, Institute for Cancer Research, American Oncologic Hospital, and FCCC Select FORM 990, PART VII CERTAIN OFFICERS AND KEY EMPLOYEES OF FOX CHASE CANCER CENTER AND AFFILIATES ALSO DEVOTE SIGNIFICANT TIME EACH WEEK TO OTHER RELATED ORGANIZATIONS. THESE HOURS ARE REFLECTED ON EACH ORGANIZATION'S RESPECTIVE TAX RETURNS. INSTITUTE FOR CANCER RESEARCH 333 COTTMAN AVENUE PHILADELPHIA PA 19111 236296135 RESEARCH DE 501(c)(3) 4 NA AMERICAN ONCOLOGIC HOSPITAL 333 COTTMAN AVENUE PHILADELPHIA PA 19111 231352156 PATIENT CARE PA 501(c)(3) 3 NA HEALTH SERVICES OF FOX CHASE CANCER CTR 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232328543 PATIENT CARE PA 501(c)(3) 3 NA FOX CHASE NETWORK 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232467337 CLINICAL SVCS PA 501(c)(3) 11B fccc FOX CHASE SELECT 76 ST PAUL STREET BURLINGTON VT 05401 020597423 CAPTIVE INSUR VT 501(c)(3) 11A aoh FOX CHASE LIMITED 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232396731 MEDICAL SERVI PA NA C CORP false true false false false false false false true true false false false false false false true true INSTITUTE FOR CANCER RESEARCH R 233806 AMERICAN ONCOLOGIC HOSPITAL R 20171826 HEALTH SERVICES OF FOX CHASE CANCER CENTER R 772790 INSTITUTE FOR CANCER RESEARCH Q 1743909 AMERICAN ONCOLOGIC HOSPITAL J 3451255 AMERICAN ONCOLOGIC HOSPITAL I 206365 INSTITUTE FOR CANCER RESEARCH B 1029987 AMERICAN ONCOLOGIC HOSPITAL C 18251470